Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Pacini

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
European Thyroid Journal|May 1, 2014
Radioactive iodine activities for postsurgical thyroid ablation: the lower the betterFurio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Thyroid microcarcinomaFurio Pacini
Thyroid : Official Journal of the American Thyroid Association|May 6, 2006
Why do we need guidelines for differentiated thyroid cancer?Furio Pacini
The Journal of Clinical Endocrinology and Metabolism|April 9, 2013
Management of papillary thyroid microcarcinoma: primum non nocere!Furio Pacini
European Thyroid Journal|May 22, 2014
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients?Furio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
PrefaceFurio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. PrefaceFurio Pacini
The Lancet. Diabetes & Endocrinology|April 29, 2022
Postsurgical radioiodine ablation in low-risk differentiated thyroid cancerFurio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Which patient with thyroid cancer deserves systemic therapy and when?Furio Pacini
Thyroid : Official Journal of the American Thyroid Association|March 18, 2008
Where do we stand with targeted therapy of refractory thyroid cancer?--Utility of RECIST criteriaFurio Pacini
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
European Thyroid Journal|May 1, 2014
Radioactive iodine activities for postsurgical thyroid ablation: the lower the betterFurio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Thyroid microcarcinomaFurio Pacini
Thyroid : Official Journal of the American Thyroid Association|May 6, 2006
Why do we need guidelines for differentiated thyroid cancer?Furio Pacini
The Journal of Clinical Endocrinology and Metabolism|April 9, 2013
Management of papillary thyroid microcarcinoma: primum non nocere!Furio Pacini
European Thyroid Journal|May 22, 2014
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients?Furio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
PrefaceFurio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. PrefaceFurio Pacini
The Lancet. Diabetes & Endocrinology|April 29, 2022
Postsurgical radioiodine ablation in low-risk differentiated thyroid cancerFurio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Which patient with thyroid cancer deserves systemic therapy and when?Furio Pacini
Thyroid : Official Journal of the American Thyroid Association|March 18, 2008
Where do we stand with targeted therapy of refractory thyroid cancer?--Utility of RECIST criteriaFurio Pacini
Pageof 15